Summary
Surface marker studies were carried out on neoplastic cell samples (peripheral aspirates and skin biopsies) of 302 patients with non-Hodgkin lymphomas (221 patients) and acute lymphatic leukaemias (81 patients). In 11 patients with non-Hodgkin lymphomas (5%) and eight patients with acute lymphatic leukaemia (10%), the neoplastic cells possessed phenotypic characteristics of T cells. The investigations were carried out by means of an indirect immunofluorescence technique using a panel of monoclonal antibodies (OKT 3, 4, 6, 8, 9, 10; OKM 1; HNK 1 and VIL A 1). In addition, conventional markers (SIg, E-R 4°, E-R 37°, absorbed polyclonal rabbit antithymus and anti-TDT) were used. Our results, which show a pronounced phenotypic surface marker heterogeneity between the group of T-cell neoplasias, emphasize the diagnostic value of monoclonal antisera as compared to polyclonal reagents. Eleven different surface marker profiles were observed in the 19 patients investigated.
Similar content being viewed by others
References
Abo T, Balch CM (1981) A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK 1). J Immunol 127:1024–1029
Aisenberg AC, Wilkes B, Long JC, Harris NL (1980) Cell surface phenotype in lymphoproliferative disease. Am J Med 68:206–213
Bollum F (1979) Terminal desoxynucleotidyl transferase as a haemopoetic marker. Blood 54:1203–1215
Breard J, Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1980) A monoclonal antibody reactive with peripheral blood monocytes. J Immunol 124:1943–1948
Greaves MF (1981) Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 41:4752–4766
Greaves MF, Rao J, Hariri G, Verbi W, Catovsky D, Kung PC, Goldstein G (1981) Phenotypic heterogeneity and cellular origins of T-cell malignancies. Leuk Res 5, 4/5:281–299
Greaves MF, Delia D, Sutherland R, Rao J, Verbi W, Kemshead J, Robinson J, Hariri G, Goldstein G, Kung PC (1981) Expression of the OKT monoclonal antibody defined antigenic determinants in malignancy. Int J Immunopharmacol 3:283–299
Habeshaw JA, Catley PF, Stansfeld AG, Brearly RL (1979) Surface phenotyping, histology and the nature of Non-Hodgkin Lymphoma in 157 patients. Br J Cancer 40:11–34
Herrmann F, Sieber G, Enders B, Bochert G, Reim J, Rühl H (1982) Chronic lymphocytic leukemia of Ty-cell type with NK and suppressor activity clinically presented as hypogammaglobulinemia: functional and surface marker characteristic of the proliferating cell clone. Immunobiol 162, 4/5:363–364
Herrmann F, Lochner A, Philippen H, Jauer B, Rühl H (1982) Imbalance of T cell subpopulations in patients with chronic lymphocytic leukemia of the B-cell type. Clin Exp Immunol 49:157–162
Herrmann F, Wirthmüller R (1982) Cell surface-marker phenotyping in patients with leukemic Non-Hodgkin Lymphomas of low and intermediate malignancy. Immunobiol 163:77–94
Ho AD, Hunstein W, Uhl N, Storch HH (1981) Bedeutung der terminalen Desoxynucleotidyl-transferase bei akuten Leukämien und malignen Lymphomen. Erfahrungen mit der Immunofluoreszenzmethode. Dtsch Med Wochenschr 106:643–647
Janossy G (1981) Differentiation of human bone marrow cells and thymocytes. In: Knapp W (ed) Leukemia Markers. Academic Press, London, New York, pp 45–56
Knapp W, Majdic O, Bettelheim P, Liszka K (1982) VIL Al, a monoclonal antibody reactive with common acute lymphatic leukemia cells. Leuk Res 6, 2:137–147
Kung PC, Goldstein G, Reinherz EL, Schlossman SF (1979) Monoclonal antibodies defining distinctive human T cell surface antigens. Science 206:347–349
Nadler LM, Ritz J, Reinherz EL, Schlossman SF (1981) Cellular origins of human leukemia and lymphoma. In: Knapp W (ed) Leukemia Markers. Academic Press, London, New York, pp 3–17
Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1979) Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol 123:2894–2896
Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF (1980) Discrete stage of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T lineage. Proc Natl Acad Sci USA 77:1588–1592
Rodt H, Thierfelder S, Thiel E, Götze D, Netzel B, Huhn D, Eulitz M (1975) Identification and quantitation of human T-cell antigen by antisera purified from antibodies cross-reacting with hemopoietic progenitors and other blood cells. Immunogenetics 2:411–430
Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves MF (1981) An ubiquitous membrane glycoprotein defined by monoclonal antibody (OKT 9) is the transferrin receptor. In: Knapp W (ed) Leukemia Markers. Academic Press, London New York, pp 157–160
Thiel E, Rodt H, Thierfelder S (1981) Leukemic cell phenotypes and the lymphoid differentiation pathway. Haematologica 66:389–408
Author information
Authors and Affiliations
Additional information
Supported in part by grants from the Tumorzentrum Berlin e. V.
Rights and permissions
About this article
Cite this article
Herrmann, F., Komischke, B., Sieber, G. et al. Heterogeneity of T-cell neoplasias as defined by monoclonal antibodies. Klin Wochenschr 61, 807–812 (1983). https://doi.org/10.1007/BF01496725
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01496725